The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin

Completed

• Conditions: Osteoporosis

• Registration Number: NCT00665613
• Lead Sponsor: Northwell Health

Brief Summary

The purpose of this study is to determine if osteoporosis is an unrecognized complication of chronic anticoagulation with warfarin.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-10
• Study First Submitted: 2008-04-22
• Study First Submitted QC: 2008-04-23
• Study First Posted: 2008-04-24
• Primary Completion: 2009-03
• Study Completion: 2009-03
• Status Verified: 2015-10
• Last Update Submitted: 2015-10-13
• Last Update Posted: 2015-10-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Patients on warfarin that have had BMD within a year

Exclusion Criteria

• Patients on bisphosphates, SERMS, anticonvulsants, estrogens, androgens, calcitonin, hctz and thyroid hormone replacement

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bone Density	5 to 10 years	bone density as measured by xray to assess bone strength nd risk of fracture

Trial Locations

Locations (1)

Staten Island University Hospital; 🇺🇸 Staten Island, New York, United States